Connect with us

Technology

Home Medical Equipment Market to be Worth $62.89 Billion by 2030 – Exclusive Report by Meticulous Research®

Published

on

REDDING, Calif., June 19, 2024 /PRNewswire/ — According to a new market research report titled, ‘Home Medical Equipment Market by Product (Therapeutic [CPAP, Nebulizer, Ventilator, Dialysis, IV Equipment] Monitoring [Cardiac, Glucose, Temperature, Apnea] Mobility Assist [Walker, Wheelchair, Scooter]) Distribution Channel – Global Forecast to 2030,’ published by Meticulous Research®, the home medical equipment market is projected to reach $62.89 billion by 2030, at a CAGR of 6.8% from 2023 to 2030.

Download Sample Report Now- https://www.meticulousresearch.com/download-sample-report/cp_id=1284 

Home medical equipment is used to fulfill patients’ healthcare needs at home. It is mostly used when a patient or individual requires prolonged care or stays in healthcare facilities. Home medical equipment includes therapeutic, mobility, assistive, and patient support equipment used by individuals or patients to control numerous conditions, such as respiratory diseases, mobility disorders, and cancer.

The key players profiled in the home medical equipment market report are Abbott Laboratories (U.S.), Amedisys, Inc (U.S.), Baxter Healthcare (U.S.), Convatec (U.K.), Fisher & Paykel Healthcare (New Zealand), Fresenius Medical Care AG & Co. KGaA (Germany), Becton, Dickinson and Company (U.S.), GE HealthCare (U.S.), Invacare Corporation (U.S.), Medtronic (Ireland), Hill-Rom Holdings, Inc. (U.S.), Smith & Nephew plc (U.K.), and Inogen, Inc. (U.S.). The report also includes an extensive assessment of the key growth strategies adopted by leading market players in the last three to four years. The global home medical equipment market has witnessed several strategic developments in the past few years.

Technological advancements in home medical equipment, the increasing prevalence of chronic diseases coupled with the rising geriatric population globally, the growing adoption of self-health management practices, and rising healthcare expenditure are driving the growth of this market.

Get a Glimpse Inside: Request Sample Pages- https://www.meticulousresearch.com/request-sample-report/cp_id=1284 

Furthermore, emerging economies are expected to offer significant opportunities for the growth of this market. However, the high costs of medical equipment and the absence of reimbursement for home medical equipment are expected to restrain the market’s growth.

Rising Healthcare Expenditure to Drive the Demand for Home Medical Equipment

Healthcare expenditure encompasses all the financial resources allocated to ensure the optimal functioning of healthcare systems and the delivery of high-quality patient care. The increasing healthcare expenditures in various countries indicate a growing emphasis on promoting overall population health and disease prevention. This trend is expected to drive the adoption of advanced medical technologies, increase funding and initiatives for disease diagnosis and treatment, and the establishment of healthcare facilities with advanced infrastructure. This rise in healthcare expenditure is observed in both developed and developing countries. The U.S. has significantly higher healthcare spending than other economies.

In 2021, healthcare spending in the U.S. reached USD 4.3 trillion, with the average healthcare cost per person being nearly USD 12,900. Furthermore, according to The Federal Statistical Office, Germany’s healthcare expenditure reached USD 560.95 billion (Euro 474.1 billion) in 2021, representing an increase compared to the previous year. Additionally, healthcare spending in Brazil is projected to rise to approximately 12.6% of GDP by 2040, an increase from 9.6% in 2019 (Source: OECD).

The global geriatric population is experiencing rapid growth. According to data from the World Health Organization, the proportion of individuals aged 60 years and above is expected to nearly double from 12% to 22% globally between 2015 and 2050. In Asia-Pacific, countries including Japan, South Korea, and Hong Kong are expected to have the largest share of people over 65 years and older by 2050. The prevalence of common conditions in older age, including diabetes, chronic obstructive pulmonary disease, cardiovascular diseases, and cancer, contributes to higher utilization of home medical equipment for home care. The elderly population, often unable to visit hospitals for regular checkups, relies on medical products that can be conveniently used at home. Therefore, the rising elderly population drives the adoption of home medical equipment.

Have Specific Research Needs? Request a Customized Report- https://www.meticulousresearch.com/request-customization/cp_id=1284 

Home Medical Equipment Market: Future Outlook

 The home medical equipment market is segmented by Product [Therapeutic Equipment {Home Respiratory Therapeutics Equipment (CPAP machines, CPAP accessories), Oxygen Delivery Equipment (Oxygen Concentrator, Nasal Cannula, Nebulizers, Ventilators (Invasive Ventilators, Non-invasive Ventilators), Humidifiers), Home IV Equipment (IV Pumps, IV Administration, IV Accessories), Home Dialysis Equipment (Home Peritoneal Dialysis Products (Consumables (Dialyzers, Concentrates/Dialysates, Bloodlines, Other Peritoneal Dialysis Consumables)), Devices (Center-Use, Home-Use), Home Hemodialysis Products (Consumables (Concentrates/Dialysates, Catheters, Other Hemodialysis Consumables)) Devices), Patient Monitoring Equipment (Cardiac Monitoring Equipment, Blood Glucose Monitoring Equipment, Temperature Monitoring Equipment, Apnea Monitoring Equipment, Other Patient Monitoring Equipment), Mobility Assist & Patient Support Equipment (Wheelchairs (Manual Wheelchairs, Powered Wheelchairs)), Walking Assist Device (Walker & Roller, Canes & Walking Sticks, Crutches), Bathroom Safety Equipment, Mobility Scooters, Medical Furniture & Accessories)}, Distribution Channel {Retail Medical Stores, Hospital Pharmacies, E-commerce Channels}, and Geography {North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa}.

Based on product, the home medical equipment market is segmented into therapeutic equipment, patient monitoring equipment, and mobility assist & patient support equipment. In 2023, the therapeutic segment is expected to account for the largest share of the home medical equipment market. Therapeutics equipment provides home care by helping individuals or patients manage their respiratory conditions & treatment at home. The growing prevalence of diseases that require frequent usage of home medical equipment, such as home dialysis equipment and intravenous pumps, the aging population, advancements in home medical equipment, and higher costs of hospitalizations contribute to the large market share of this segment.

Among the distribution channels covered in this study, in 2023, the retail medical stores segment is expected to account for the largest share of the home medical equipment market. The large market share of this segment is attributed to the easy availability and accessibility of home medical equipment and lower operating costs. Retail medical stores offer a wide range of products and other medical supplies. Retail medical stores offer a wide range of products and medical supplies, providing convenient access for patients needing home medical equipment and supplies. The convenience offered by these stores contributes to the significant market share of this segment.

Based on geography, the home medical equipment market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is expected to account for the largest share of the home medical equipment market. North America’s major market share is attributed to the growing aging population, the increasing prevalence of chronic diseases that necessitate the use of home medical equipment, the ongoing development of healthcare infrastructure, and the rising healthcare expenditures in the region.

However, Asia-Pacific is projected to register the highest CAGR during the forecast period. The growth of this regional market is attributed to growing investments in home healthcare in emerging countries like China, Japan, and India, the rising preference for home-based treatments due to higher hospitalization costs, government initiatives promoting home care, and the growing prevalence of chronic diseases due to the aging population.

Browse In-depth Report Now- https://www.meticulousresearch.com/product/home-medical-equipment-market-1284 

Scope of the Report:

Home Medical Equipment Market Assessment—by Product

Therapeutic EquipmentHome Respiratory Therapeutics EquipmentCPAP MachinesCPAP AccessoriesOxygen Delivery EquipmentOxygen ConcentratorsNasal CannulaNebulizersVentilatorsInvasive VentilatorsNon-invasive VentilatorsHumidifiersHome IV EquipmentIV PumpsIV AdministrationIV AccessoriesHome Dialysis EquipmentHome Peritoneal Dialysis ProductsConsumablesDialyzersConcentrates/DialysatesBloodlinesOther Peritoneal Dialysis ConsumablesDevicesCenter-UseHome-UseHome Hemodialysis ProductsConsumablesConcentrates/DialysatesCathetersOther Hemodialysis ConsumablesDevicesPatient Monitoring EquipmentCardiac Monitoring EquipmentBlood Glucose Monitoring EquipmentTemperature Monitoring EquipmentApnea Monitoring EquipmentOther Patient Monitoring EquipmentMobility Assist & Patient Support EquipmentWheelchairsManual WheelchairsPowered WheelchairsWalking Assist DevicesWalkers & RollersCanes & Walking SticksCrutchesBathroom Safety EquipmentMobility ScootersMedical Furniture & Accessories

Home Medical Equipment Market Assessment—by Distribution Channel

Retail Medical StoresHospital PharmaciesE-commerce Channels

Home Medical Equipment Market Assessment—by Geography

North AmericaU.S.CanadaEuropeU.K.GermanyFranceItalySpainSwitzerlandNetherlandsBelgiumRest of EuropeAsia-PacificChinaJapanIndiaRest of Asia-PacificLatin AmericaBrazilMexicoRest of Latin AmericaMiddle East & AfricaSaudi ArabiaUAERest of Middle East & Africa

Unlock Opportunities: Buy Now- https://www.meticulousresearch.com/Checkout/25071940 

Related Reports:

Home Healthcare Market by Offering (Fertility, Pregnancy, Cholesterol Tests, Oximeters, CPAP, Nebulizers, Ventilators, Dialysis, Patient Support Equipment), Services (Rehabilitation, Telehealth, Nursing, Hospice), Application (Cardiovascular, Diabetes, Respiratory) – Global Forecast to 2030

Latin America Home Healthcare Market by Offering (Equipment [Therapeutic {Insulin, Dialysis}, Diagnostic {Blood Pressure, Heart Rate}, Mobility], Services [Skilled {Primary Care, Nursing Nutritional}], Application (CVD, Diabetes, Cancer) – Forecast to 2030

Infusion Pumps Market by Product (Devices [Volumetric, Insulin, Enteral, Ambulatory, PCA], Accessories, Smart Infusion System), Application (Hormones, Antibiotics, Chemotherapy drugs), End User (Hospital, Home Health Care, ACS) – Global Forecast to 2024

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe: +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Content Source: https://www.meticulousresearch.com/pressrelease/363/home-medical-equipment-market-2030

Logo: https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/home-medical-equipment-market-to-be-worth-62-89-billion-by-2030—exclusive-report-by-meticulous-research-302176856.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

AFRICON 2025 Returns to Atlanta on September 18-20, 2025

Published

on

By

AFRICON, the flagship convening for global African changemakers, tastemakers, and innovators, officially returns to Atlanta, Georgia on September 18–20, 2025. Hosted by Amplify Africa, this year’s edition marks a new era of global connection, cultural elevation, and cross-continental collaboration—bringing together thousands of attendees from across Africa, the Diaspora, and the world.

ATLANTA, May 16, 2025 /PRNewswire-PRWeb/ — The Premier Global Gathering Celebrating African Culture, Creativity, and Commerce Expands with New Partnerships

“AFRICON is more than a conference—it’s a cultural and economic movement,” said Timi Adeyeba, COO & Co-Founder of Amplify Africa.

AFRICON, the flagship convening for global African changemakers, tastemakers, and innovators, officially returns to Atlanta, Georgia on September 18–20, 2025. Hosted by Amplify Africa, the 2025 edition, will showcase panels, workshops, pitch competitions, music showcases, fashion bazaars, and a film festival. This year’s edition marks a new era of global connection, cultural elevation, and cross-continental collaboration—bringing together thousands of attendees from across Africa, the Diaspora, and the world.

“AFRICON is more than a conference—it’s a cultural and economic movement,” said Timi Adeyeba, COO & Co-Founder of Amplify Africa.

“Each year, we’re building bridges across continents and creating a global platform that celebrates who we are while shaping where we’re going,” said Dami Kujembola, CEO & Co-Founder of Amplify Africa.

This year, AFRICON is proud to announce a headline partnership with Fidelity Bank, one of Africa’s most respected financial institutions. As part of this collaboration, AFRICON 2025 will feature the 3rd Annual Fidelity Investment and Trade Creative Connect (FITCC)—a marquee forum designed to spotlight innovation, entrepreneurship, and cross-border investment opportunities across the African continent.

“Since 2022, when we hosted the maiden edition, the FITCC has evolved beyond a platform for promoting Nigeria’s non-oil exports to become a veritable showcase of the immense value Nigeria has to offer the global market,” stated Dr. Nneka Onyeali-Ikpe, OON, Managing Director/Chief Executive Officer of Fidelity Bank Plc. “As part of our commitment to developing platforms that promote economic growth, creativity, and sustainable trade both within Nigeria and internationally, we are pleased to collaborate with AFRICON to host FITCC. This initiative stems from AFRICON’s esteemed capability to unite key stakeholders dedicated to integrating Nigerian businesses into global supply chain networks.”

AFRICON 2025 will feature a dynamic lineup of programming including cultural showcases, policy roundtables, business summits, nightlife experiences, and wellness activations. From creative industries and tech innovation to investment, trade, and social impact, the two-day experience positions Africa and its Diaspora as a rising global force.

Projected Impact

It is expected that AFRICON 2025 will attract:Over 3,000 attendees from around the worldMore than 200 exhibitors and businesses across sectorsOver US$200 million in trade, investment, and partnership deals to be concluded

AFRICON 2025 continues to build on its legacy of convening a global network of decision-makers, creatives, executives, and community leaders who are shaping Africa’s future.

For more information on tickets, sponsorship opportunities, and programming details, visit www.africon.global or follow @africon.global on all platforms.

About Amplify Africa

Amplify Africa is a leading media, events, and cultural agency dedicated to shaping the global narrative of Africa and its Diaspora. With a reach of over 12 million people monthly, Amplify Africa curates impactful experiences, content, and campaigns that celebrate African excellence across entertainment, tech, business, and culture. From landmark festivals to thought leadership summits, the platform serves as a bridge between Africa and the world—empowering the next generation of changemakers and creators.

About Fidelity Bank

Fidelity Bank Plc is a full-fledged commercial bank with over 9.1 million customers who are serviced across its 251 business offices and various digital banking channels in Nigeria and the United Kingdom.

The Bank is the recipient of multiple local and international Awards, including the 2024 Excellence in Digital Transformation & MSME Banking Award by BusinessDay Banks and Financial Institutions (BAFI) Awards; the 2024 Most Innovative Mobile Banking Application award for its Fidelity Mobile App by Global Business Outlook, and the 2024 Most Innovative Investment Banking Service Provider award by Global Brands Magazine. Additionally, the Bank was recognized as the Best Bank for SMEs in Nigeria by the Euromoney Awards for Excellence and as the Export Financing Bank of the Year by the BusinessDay Banks and Financial Institutions (BAFI) Awards.

Media Contact
Amplify Africa, Amplify Africa, 1 2138140719, info@amplifyafrica.org, https://amplifyafrica.co/

View original content to download multimedia:https://www.prweb.com/releases/africon-2025-returns-to-atlanta-on-september-1820-2025-302456185.html

SOURCE Amplify Africa

Continue Reading

Technology

Movano Health’s Board of Directors Initiates Process to Maximize Shareholder Value

Published

on

By

PLEASANTON, Calif., May 16, 2025 /PRNewswire/ — Movano Health (Nasdaq: MOVE), a pioneer in health technology, announced today that its Board of Directors has initiated a process to explore strategic alternatives, including a sale, merger or similar transaction involving the Company, to maximize shareholder value.  To support this process, Movano Health’s Board of Directors has engaged Aquilo Partners as its financial advisor and K&L Gates LLP as its legal counsel.

There can be no assurance that this process will result in any transaction or other strategic change or as to the timing of any such potential agreement or transaction. Movano Health does not intend to disclose further developments unless and until the Board of Directors has approved a specific course of action or determines that further disclosure is appropriate or required.  The Company also reported that due to resource constraints, it does not plan to timely file its quarterly report on Form 10-Q for the quarter ended March 31, 2025.

About Movano Health 
Founded in 2018, Movano Inc. (Nasdaq: MOVE) dba Movano Health is developing a suite of purpose-driven healthcare solutions to bring medical-grade data to the forefront of wearables. Featuring modern and flexible form factors, Movano Health’s devices offer an innovative approach to delivering trusted data to both customers and enterprises, capturing a comprehensive picture of an individual’s health data and uniquely translating it into personalized and intelligent insights.

Movano Health’s proprietary technologies and wearable medical device solutions enable the use of data as a tool to proactively monitor and manage health outcomes across a number of patient populations that exist in healthcare. For more information on Movano Health, visit https://movanohealth.com/.

Forward Looking Statements

This press release contains forward-looking statements concerning our expectations, anticipations, intentions, beliefs, or strategies regarding the future. These forward-looking statements are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties that could cause actual results, conditions, and events to differ materially from those anticipated. Therefore, you should not place undue reliance on forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding the Company’s strategic plans and value, plans with respect to the commercial launches of the Evie Ring and EvieMED; our expectations regarding potential commercial opportunities and addressable markets; planned cost-cutting initiatives; anticipated FDA clearance decisions with respect to our products; expected future operating results; product development efforts and product releases; clinical trial and regulatory initiatives; commercial partner activities; our strategies, positioning and expectations for future events or performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, and in our other reports filed with the Securities and Exchange Commission, including under the caption “Risk Factors.”  Any forward-looking statement in this release speaks only as of the date of this release. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

View original content to download multimedia:https://www.prnewswire.com/news-releases/movano-healths-board-of-directors-initiates-process-to-maximize-shareholder-value-302458030.html

SOURCE Movano

Continue Reading

Technology

Canaan Inc. Receives Nasdaq Notification Regarding Minimum Bid Requirements

Published

on

By

SINGAPORE, May 16, 2025 /PRNewswire/ — Canaan Inc. (NASDAQ: CAN) (“Canaan” or the “Company”), an innovator in crypto mining, today announced that on May 13, 2025, it received a written notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2), as the closing bid price of its American depositary shares (the “ADSs”) was below US$1.00 per share for the last 30 consecutive business days. The Nasdaq notification letter has no immediate effect on the listing or trading of the Company’s securities on Nasdaq.

Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted a 180-calendar-day compliance period, or until November 10, 2025, to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Company’s ADSs must meet or exceed US$1.00 per share for at least 10 consecutive business days during the 180-calendar-day compliance period.

In the event the Company does not regain compliance by November 10, 2025, subject to the determination by the staff of Nasdaq, the Company may be eligible for an additional 180-calendar-day compliance period. To qualify for this additional time, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market with the exception of the minimum bid price requirement and will need to provide written notice of its intention to cure the deficiency during the second compliance period. If the Company does not regain compliance within the allotted compliance period(s), including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Company’s ADSs will be subject to delisting.

The Company intends to continue monitoring the closing bid price of its ADSs and will take all reasonable measures in order to regain compliance with the Nasdaq minimum bid price requirement. The Company’s ADSs will continue to be listed and trade on the Nasdaq Global Market during the compliance period, unaffected by the receipt of the Notice from Nasdaq.

This announcement is made in compliance with Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification.

About Canaan Inc.

Established in 2013, Canaan Inc. (NASDAQ: CAN), is a technology company focusing on ASIC high-performance computing chip design, chip research and development, computing equipment production, and software services. Canaan has extensive experience in chip design and streamlined production in the ASIC field. In 2013, Canaan’s founding team shipped to its customers the world’s first batch of mining machines incorporating ASIC technology in bitcoin‘s history under the brand name Avalon. In 2019, Canaan completed its initial public offering on the Nasdaq Global Market. To learn more about Canaan, please visit https://www.canaan.io/.

Safe Harbor Statement

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Among other things, the business outlook and quotations from management in this announcement, as well as Canaan Inc.’s strategic and operational plans, contain forward-looking statements. Canaan Inc. may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (“SEC”) on Forms 20-F and 6-K, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about Canaan Inc.’s beliefs and expectations, such as expectations with regard to mining hash rate deployment, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company’s goals and strategies; the Company’s future business development, the ability of the company to execute against its goals, financial condition and results of operations; the expected growth of the bitcoin industry and the price of bitcoin; the Company’s expectations regarding demand for and market acceptance of its products, especially its bitcoin mining machines; the Company’s expectations regarding maintaining and strengthening its relationships with production partners and customers; the Company’s investment plans and strategies, fluctuations in the Company’s quarterly operating results; competition in its industry; changing macroeconomic and geopolitical conditions, including evolving international trade policies and the implementation of increased tariffs, import restrictions, and retaliatory trade actions; and relevant government policies and regulations relating to the Company and cryptocurrency. Further information regarding these and other risks is included in the Company’s filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and Canaan Inc. does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Investor Relations Contact

Canaan Inc.
Xi Zhang
Email: IR@canaan-creative.com

ICR, LLC.
Robin Yang
Tel: +1 (347) 396-3281
Email: canaan.ir@icrinc.com

View original content:https://www.prnewswire.com/news-releases/canaan-inc-receives-nasdaq-notification-regarding-minimum-bid-requirements-302458116.html

SOURCE Canaan Inc.

Continue Reading

Trending